The term “hereditary TP53‐associated tumor syndrome” was suggested by the European Reference Network (ERN) GENTURIS to account for growing evidence of the variable penetrance observed in TP53 germline carriers.9, 14, 15. This evidence concerns the gene TP53 and neoplastic syndrome.